A
Ann C. Childress
Researcher at Baylor College of Medicine
Publications - 107
Citations - 2465
Ann C. Childress is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Medicine. The author has an hindex of 25, co-authored 84 publications receiving 2040 citations. Previous affiliations of Ann C. Childress include University of California, Irvine & Medical University of South Carolina.
Papers
More filters
Journal ArticleDOI
The Kids' Eating Disorders Survey (KEDS): A Study of Middle School Students
TL;DR: Findings demonstrate that development of prevention programs aimed at recognizing problem eating behavior in children is indicated and are demonstrated to be significantly greater in girls than boys.
Journal ArticleDOI
Practitioner Review: Emotional dysregulation in attention‐deficit/hyperactivity disorder – implications for clinical recognition and intervention
Stephen V. Faraone,Anthony L. Rostain,Joseph C. Blader,Betsy Busch,Ann C. Childress,Daniel F. Connor,Jeffrey H. Newcorn +6 more
TL;DR: The various terms used to define emotional symptoms in ADHD are reviewed, how these symptoms are demarcated from mood disorders are clarified, and the possibility that symptoms of emotional impulsivity and deficient emotional self-regulation should be considered as core symptoms of ADHD are assessed.
Journal ArticleDOI
Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study
Joseph Biederman,Samuel W. Boellner,Ann C. Childress,Frank A. Lopez,Suma Krishnan,Yuxin Zhang +5 more
TL;DR: In a laboratory classroom environment, LDX significantly improved ADHD symptoms versus placebo in school-age children with ADHD in an analog classroom setting.
Journal ArticleDOI
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
Robert L. Findling,Ann C. Childress,Andrew J. Cutler,Maria Gasior,Mohamed Hamdani,M. Celeste Ferreira-Cornwell,Liza Squires +6 more
TL;DR: LDX at all doses was effective versus placebo in treating adolescent ADHD and demonstrated a safety profile consistent with previous LDX studies.
Journal ArticleDOI
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
TL;DR: In school-aged children (6 to 12 years) with ADHD, efficacy of LDX was maintained from the first time point up to the last time point assessed, and was generally well tolerated, resulting in typical stimulant AEs.